Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders

All NewsJune 11, 2026

Vertex Reports CASGEVY Data Showing Sustained Benefits In Children With Sickle Cell Disease And Beta Thalassemia

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT